Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Core Isogenics is a biotechnology company specializing in the development of isogenic cannabis seed strains and automated cultivation technologies. Based in Adelanto, California, the company operates as a subsidiary of Core One Labs and maintains a state-of-the-art nursery and cultivation facility. Its core business involves producing genetically stable cannabis biomass with consistent cannabinoid profiles for use in pharmaceutical-grade delivery systems, such as thin-film oral strips. By leveraging advanced agricultural biotechnology, Core Isogenics aims to standardize cannabis production for medical and wellness applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Core Isogenetics.